Peptides
99.5% HPLC
Tirzepatide
Dual GLP-1 / GIP agonist. Clinical-grade metabolic research.
$136.00
Peptides
Retatrutide
Triple agonist (GLP-1 / GIP / Glucagon). Next-generation metabolic compound.
Dosage
30mg / vial
Purity
99.4% · HPLC
Form
Lyophilized powder
Storage
Refrigerate 2-8°C. Stable 30 days reconstituted.
Mechanism
Simultaneous agonism of GLP-1, GIP, and glucagon receptors drives glycemic modulation and adipose mobilization.
Certificate of analysis included
Tracked shipping · discreet packaging
Research use only
